share_log

Craig-Hallum Maintains Hold on Accelerate Diagnostics, Lowers Price Target to $1

Benzinga ·  Apr 2 02:00

Craig-Hallum analyst Alexander Nowak maintains Accelerate Diagnostics (NASDAQ:AXDX) with a Hold and lowers the price target from $2 to $1.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment